浙江医学
浙江醫學
절강의학
ZHEJIANG MEDICAL JOURNAL
2013年
20期
1802-1806
,共5页
戴璇璇%周毅力%刘超%闫东升%王瓯晨
戴璇璇%週毅力%劉超%閆東升%王甌晨
대선선%주의력%류초%염동승%왕구신
甲状腺乳头状癌%微小RNA%芯片%RNA印迹杂交法
甲狀腺乳頭狀癌%微小RNA%芯片%RNA印跡雜交法
갑상선유두상암%미소RNA%심편%RNA인적잡교법
Papillary thyroid carcinoma%MiRNAs%Microarray%Northern blot
目的:探讨甲状腺乳头状癌(PTC)中特征性的miRNA表达谱以及临床病理意义。方法对52例PTC及7例良性甲状腺肿瘤手术切除标本采用基因芯片技术及RNA印迹杂交法检测miRNA的表达,对过表达的miRNA表达水平与PTC临床病理特征之间的关系进行分析。结果(1)用基因芯片技术筛检发现 PTC 组织中5例过表达的 miRNAs(miR-375、miR-34a、miR-146b、miR-222、miR-31)。(2)RNA印迹杂交法验证芯片结果及检测其他miRNAs结果显示:miR-34a、miR-146b、miR-31、miR-21和miR-221在PTC组织中的表达水平较癌旁正常甲状腺组织显著升高(P<0.05)。MiR-146b和miR-221在PTC组织中的过表达率较良性甲状腺肿瘤组织显著升高(P<0.01)。PTC患者中包膜侵犯组、淋巴结转移组、TNM分期III- IV期组及AGES系统评分≥5分组miR-221的表达水平均明显高于相应对照组(P<0.05或0.01);而男性PTC患者的miR-146b表达水平明显高于女性PTC患者(P<0.05)。结论 miR-146b、miR-221、miR-21和miR-31的过表达与PTC的发生、发展有关;过表达的miR-221和miR-146b与PTC的预后不良有关。
目的:探討甲狀腺乳頭狀癌(PTC)中特徵性的miRNA錶達譜以及臨床病理意義。方法對52例PTC及7例良性甲狀腺腫瘤手術切除標本採用基因芯片技術及RNA印跡雜交法檢測miRNA的錶達,對過錶達的miRNA錶達水平與PTC臨床病理特徵之間的關繫進行分析。結果(1)用基因芯片技術篩檢髮現 PTC 組織中5例過錶達的 miRNAs(miR-375、miR-34a、miR-146b、miR-222、miR-31)。(2)RNA印跡雜交法驗證芯片結果及檢測其他miRNAs結果顯示:miR-34a、miR-146b、miR-31、miR-21和miR-221在PTC組織中的錶達水平較癌徬正常甲狀腺組織顯著升高(P<0.05)。MiR-146b和miR-221在PTC組織中的過錶達率較良性甲狀腺腫瘤組織顯著升高(P<0.01)。PTC患者中包膜侵犯組、淋巴結轉移組、TNM分期III- IV期組及AGES繫統評分≥5分組miR-221的錶達水平均明顯高于相應對照組(P<0.05或0.01);而男性PTC患者的miR-146b錶達水平明顯高于女性PTC患者(P<0.05)。結論 miR-146b、miR-221、miR-21和miR-31的過錶達與PTC的髮生、髮展有關;過錶達的miR-221和miR-146b與PTC的預後不良有關。
목적:탐토갑상선유두상암(PTC)중특정성적miRNA표체보이급림상병리의의。방법대52례PTC급7례량성갑상선종류수술절제표본채용기인심편기술급RNA인적잡교법검측miRNA적표체,대과표체적miRNA표체수평여PTC림상병리특정지간적관계진행분석。결과(1)용기인심편기술사검발현 PTC 조직중5례과표체적 miRNAs(miR-375、miR-34a、miR-146b、miR-222、miR-31)。(2)RNA인적잡교법험증심편결과급검측기타miRNAs결과현시:miR-34a、miR-146b、miR-31、miR-21화miR-221재PTC조직중적표체수평교암방정상갑상선조직현저승고(P<0.05)。MiR-146b화miR-221재PTC조직중적과표체솔교량성갑상선종류조직현저승고(P<0.01)。PTC환자중포막침범조、림파결전이조、TNM분기III- IV기조급AGES계통평분≥5분조miR-221적표체수평균명현고우상응대조조(P<0.05혹0.01);이남성PTC환자적miR-146b표체수평명현고우녀성PTC환자(P<0.05)。결론 miR-146b、miR-221、miR-21화miR-31적과표체여PTC적발생、발전유관;과표체적miR-221화miR-146b여PTC적예후불량유관。
Objective To investigate expression of specific miRNAs in papillary thyroid carcinoma (PTC) and their clini-copathological significance. Methods Fifty two surgical specimens of PTC tissues and 7 specimens of benign thyroid tumor tis-sues were col ected. The miRNA expression levels were detected by using microarray and Northern blot. The correlation between over- expressed miRNAs and clinicopathological features of PTC were analyzed. Results A set of 5 over- expressed miRNAs (miR- 375, miR- 34a, miR- 146b, miR- 222, miR- 31) was distinguished by microarray in PTC tissues compared to cancer- adja-cent tissues. Using Northern blot, the results of microarray were verified;and Northern blot results also showed that the expres-sion levels of miR- 34a, miR- 146b, miR- 31, miR- 221 and miR- 21 in PTC were significantly higher than those in cancer- adjacent tissues(P<0.05). Additional y, the over- expression rates of miR- 146b and miR- 221 in PTC tissues were significantly higher than those in benign thyroid tumor tissues (P<0.01). The expression levels of miR- 221 in PTC patients with extrathyroidal invasion, lymph node metastasis, advanced TNM stage (III- IV) and AGES score≥5 were significantly higher than those in control groups (P<0.05 or 0.01);whereas the expression level of miR- 146b in male PTC patients was significantly higher than that in female PTC patients (P<0.05). Conclusion Over- expression of miR- 146b, miR- 221, miR- 21, and miR- 31 may be associated with car-cinogenesis and progression of PTC, and the over- expression of miR- 221 and miR- 146b are also correlated with poor clinical outcome of PTC patients.